Clinical aspects of multiple endocrine neoplasia type 1
A Al-Salameh, G Cadiot, A Calender… - Nature Reviews …, 2021 - nature.com
Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by the co-
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …
Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis
CDC Kamilaris, CA Stratakis - Frontiers in endocrinology, 2019 - frontiersin.org
Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary tumor syndrome inherited in
an autosomal dominant manner and characterized by a predisposition to a multitude of …
an autosomal dominant manner and characterized by a predisposition to a multitude of …
Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine …
B Niederle, A Selberherr, DK Bartsch, ML Brandi… - …, 2021 - karger.com
The better understanding of the biological behavior of multiple endocrine neoplasia type 1
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
I Coutinho, TK Day, WD Tilley… - Endocrine-related …, 2016 - erc.bioscientifica.com
The androgen receptor (AR) signaling axis drives all stages of prostate cancer, including the
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …
Multiple endocrine neoplasia type 1
Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited syndrome caused by
inactivating heterozygote mutations of the MEN1 gene affecting parathyroid glands …
inactivating heterozygote mutations of the MEN1 gene affecting parathyroid glands …
Genetics of hereditary forms of primary hyperparathyroidism
KA English, KE Lines, RV Thakker - Hormones, 2024 - Springer
Primary hyperparathyroidism (PHPT), a relatively common disorder characterized by
hypercalcemia with raised or inappropriately normal serum parathyroid hormone (PTH) …
hypercalcemia with raised or inappropriately normal serum parathyroid hormone (PTH) …
Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe …
EV Cristina, F Alberto - Best Practice & Research Clinical Endocrinology & …, 2018 - Elsevier
While primary hyperparathyroidism (PHPT) generally represents a common endocrine
disorder, being the more frequent cause of hypercalcemia in outpatients, familial forms of …
disorder, being the more frequent cause of hypercalcemia in outpatients, familial forms of …
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies
M Chandran, JP Bilezikian, J Lau, R Rajeev… - Reviews in Endocrine …, 2022 - Springer
Cinacalcet, a positive allosteric modulator of the calcium sensing receptor (CaSR) reduces
parathyroid hormone (PTH) secretion by increasing the sensitivity of the CaSR on …
parathyroid hormone (PTH) secretion by increasing the sensitivity of the CaSR on …
Familial and hereditary forms of primary hyperparathyroidism
F Cetani, F Saponaro, S Borsari, C Marcocci - Parathyroid Disorders, 2019 - karger.com
Individuals with a familial predisposition to the development of parathyroid tumors constitute
a small minority of all patients with primary hyperparathyroidism (PHPT). These familial …
a small minority of all patients with primary hyperparathyroidism (PHPT). These familial …
Contemporary medical management of primary hyperparathyroidism: a systematic review
JS Leere, J Karmisholt, M Robaczyk… - Frontiers in …, 2017 - frontiersin.org
Introduction Primary hyperparathyroidism is increasingly an asymptomatic disease at
diagnosis, but the recognized guidelines for management are based on evidence obtained …
diagnosis, but the recognized guidelines for management are based on evidence obtained …